• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TAVI induces an elevation of hemostasis-related biomarkers, which is not causative for post-TAVI thrombocytopenia.

作者信息

Sedaghat Alexander, Falkenberg Nora, Sinning Jan-Malte, Kulka Hannah, Hammerstingl Christoph, Nickenig Georg, Oldenburg Johannes, Pötzsch Bernd, Werner Nikos

机构信息

Med. Klinik und Poliklinik II, Universitätsklinikum Bonn, Bonn, Germany.

Institute of Experimental Hematology and Transfusion Medicine, Universitätsklinikum Bonn, Bonn, Germany.

出版信息

Int J Cardiol. 2016 Oct 15;221:719-25. doi: 10.1016/j.ijcard.2016.07.094. Epub 2016 Jul 5.

DOI:10.1016/j.ijcard.2016.07.094
PMID:27424316
Abstract

BACKGROUND

Thrombocytopenia after transcatheter aortic valve implantation (TAVI) has been evaluated in several studies, but the pathomechanisms behind this phenomenon are not well described. Here, we assess the influence of TAVI on hemostasis-related biomarkers and their potential role in post-TAVI thrombocytopenia.

METHODS AND RESULTS

We assessed perioperative platelet counts in 307 patients undergoing transfemoral TAVI. Additionally, hemostasis-related biomarkers including thrombin-anti-thrombin complex (TAT), prothrombin activation fragment 1+2 (F1+2), plasmin-α₂-antiplasmin complex (PAP), and d-dimer were assessed in a subcohort of 35 patients. The course of these parameters was correlated with platelet counts and compared in patients with and without a relevant thrombocytopenia, i.e., a decline in platelet count of ≥50% compared to baseline. Levels of TAT (8.6±8.7μg/l), PAP (992±597μg/l), and d-dimer (1.43±1.66mg/l) were elevated above normal range before TAVI. TAT, F1+2, and d-dimer significantly increased after TAVI, and d-dimer as well as PAP remained elevated until day 7, indicating TAVI-induced increased thrombin formation associated with secondary fibrinolysis. Post-TAVI thrombocytopenia occurred in 17.9% of patients and was associated with a significantly higher incidence of post-TAVI complications, e.g. acute kidney injury and vascular complications. No impact of activated coagulation on thrombocytopenia was observed.

CONCLUSIONS

TAVI induces an increase in hemostasis-related biomarkers, which persists until 1week after the procedure. The frequent finding of post-TAVI thrombocytopenia appears not to be linked to increased thrombin formation.

摘要

相似文献

1
TAVI induces an elevation of hemostasis-related biomarkers, which is not causative for post-TAVI thrombocytopenia.
Int J Cardiol. 2016 Oct 15;221:719-25. doi: 10.1016/j.ijcard.2016.07.094. Epub 2016 Jul 5.
2
The causes of thrombocytopenia after transcatheter aortic valve implantation.经导管主动脉瓣植入术后血小板减少症的病因。
Thromb Res. 2017 Aug;156:39-44. doi: 10.1016/j.thromres.2017.05.020. Epub 2017 May 26.
3
Perioperative thrombocytopenia predicts poor outcome in patients undergoing transcatheter aortic valve implantation.围手术期血小板减少预示着经导管主动脉瓣植入术患者的不良预后。
Adv Med Sci. 2018 Mar;63(1):179-184. doi: 10.1016/j.advms.2017.11.001. Epub 2017 Nov 13.
4
Thrombocytopenia associated with TAVI-The summary of possible causes.
Adv Med Sci. 2017 Sep;62(2):378-382. doi: 10.1016/j.advms.2017.04.003. Epub 2017 May 25.
5
Impact of Transcatheter Aortic Valve Implantation on Thrombin Generation and Platelet Function.经导管主动脉瓣植入术对凝血酶生成和血小板功能的影响。
Thromb Haemost. 2021 Oct;121(10):1310-1316. doi: 10.1055/s-0041-1725190. Epub 2021 Mar 23.
6
Major thrombocytopenia after balloon-expandable transcatheter aortic valve replacement: prognostic implications and comparison to surgical aortic valve replacement.球囊扩张式经导管主动脉瓣置换术后严重血小板减少症:预后意义及与外科主动脉瓣置换术的比较
Catheter Cardiovasc Interv. 2015 Jan 1;85(1):130-7. doi: 10.1002/ccd.25430. Epub 2014 Feb 27.
7
Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.体外膜肺氧合中凝血和纤维蛋白溶解激活标志物的年龄差异。
Pediatr Crit Care Med. 2014 Jun;15(5):e198-205. doi: 10.1097/PCC.0000000000000107.
8
Coagulation, fibrinolysis and platelet drop in patients undergoing transfemoral transcatheter aortic valve implantation.经股动脉经导管主动脉瓣植入术患者的凝血、纤溶和血小板下降。
Catheter Cardiovasc Interv. 2024 Nov;104(6):1281-1289. doi: 10.1002/ccd.31199. Epub 2024 Aug 21.
9
Blood Coagulation Changes With or Without Direct Oral Anticoagulant Therapy Following Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术后直接口服抗凝治疗或不治疗的凝血变化。
Am J Cardiol. 2021 May 15;147:88-93. doi: 10.1016/j.amjcard.2021.01.042. Epub 2021 Feb 20.
10
Impact of post-procedural hyperglycemia on acute kidney injury after transcatheter aortic valve implantation.经导管主动脉瓣植入术后高血糖对急性肾损伤的影响。
Int J Cardiol. 2016 Oct 15;221:892-7. doi: 10.1016/j.ijcard.2016.07.029. Epub 2016 Jul 10.

引用本文的文献

1
Thrombin generation and clot lysis time to predict outcomes in patients undergoing transcatheter aortic valve implantation.凝血酶生成和凝血溶解时间用于预测经导管主动脉瓣植入患者的预后。
J Thromb Thrombolysis. 2025 Apr;58(4):503-513. doi: 10.1007/s11239-025-03090-6. Epub 2025 Apr 5.
2
Periprocedural Thrombogenicity Change Is Associated With Subclinical Leaflet Thrombosis Progression in Patients Undergoing Transcatheter Aortic Valve Implantation.围手术期血栓形成性变化与接受经导管主动脉瓣植入术患者的亚临床瓣叶血栓形成进展相关。
Circ Rep. 2023 Nov 30;5(12):450-458. doi: 10.1253/circrep.CR-23-0092. eCollection 2023 Dec 8.
3
Transcatheter aortic valve thrombosis: a review of potential mechanisms.
经导管主动脉瓣血栓形成:潜在机制的综述。
J R Soc Interface. 2021 Nov;18(184):20210599. doi: 10.1098/rsif.2021.0599. Epub 2021 Nov 24.
4
Quantitative and Qualitative Platelet Derangements in Cardiac Surgery and Extracorporeal Life Support.心脏手术及体外生命支持中的血小板定量和定性紊乱
J Clin Med. 2021 Feb 6;10(4):615. doi: 10.3390/jcm10040615.
5
Predictors and Biomarkers of Subclinical Leaflet Thrombosis after Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术后亚临床瓣叶血栓形成的预测因素和生物标志物
J Clin Med. 2020 Nov 21;9(11):3742. doi: 10.3390/jcm9113742.
6
Predictors of short-term thrombocytopenia after transcatheter aortic valve implantation: a retrospective study at a single Japanese center.经导管主动脉瓣植入术后短期血小板减少的预测因素:日本单中心回顾性研究。
BMC Res Notes. 2020 Nov 16;13(1):536. doi: 10.1186/s13104-020-05386-7.
7
Measuring beta-galactose exposure on platelets: Standardization and healthy reference values.测量血小板上β-半乳糖的暴露情况:标准化及健康参考值
Res Pract Thromb Haemost. 2020 Jun 2;4(5):813-822. doi: 10.1002/rth2.12369. eCollection 2020 Jul.
8
Can Blood Biomarkers Help Predicting Outcome in Transcatheter Aortic Valve Implantation?血液生物标志物能否帮助预测经导管主动脉瓣植入术的结果?
Front Cardiovasc Med. 2018 Mar 28;5:31. doi: 10.3389/fcvm.2018.00031. eCollection 2018.